Indeed cross-species comparison of the gene set associated with LSC maintenance in murine MLL-AF9 AML cells showed significantly higher expression in post- versus pre-chemotherapy human AML cells, and vice versa for genes whose expression is anti-correlated with leukemia stem cell activity (Table S4 and Fig. 3A). The gene discussed is MLLT3; the disease is leukemia.